Biogen
BIIB
BIIB
925 hedge funds and large institutions have $24.8B invested in Biogen in 2022 Q2 according to their latest regulatory filings, with 78 funds opening new positions, 296 increasing their positions, 353 reducing their positions, and 94 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
3% less funds holding
Funds holding: 950 → 925 (-25)
16% less repeat investments, than reductions
Existing positions increased: 296 | Existing positions reduced: 353
17% less first-time investments, than exits
New positions opened: 78 | Existing positions closed: 94
Holders
925
Holding in Top 10
13
Calls
$974M
Puts
$1.03B
Top Buyers
| 1 | +$130M | |
| 2 | +$103M | |
| 3 | +$89.7M | |
| 4 |
Morgan Stanley
New York
|
+$86.1M |
| 5 |
D.E. Shaw & Co
New York
|
+$74M |
Top Sellers
| 1 | -$178M | |
| 2 | -$168M | |
| 3 | -$111M | |
| 4 |
American Century Companies
Kansas City,
Missouri
|
-$92.3M |
| 5 |
Two Sigma Investments
New York
|
-$85.6M |